US isotope manufacturer takes step toward production

SHINE Medical Technologies is moving its headquarters from the Madison area to Janesville, WI. All employees will relocate to the new building, and continue preparing for the construction of SHINE’s radioisotope production facility.

SHINE is part of a National Nuclear Security Administration (NNSA) program to create domestic radioisotope manufacturers, implemented in preparation for the October shutdown of the National Research Universal reactor in Ontario. SHINE is among a handful of grant recipients and has received more than $16 million from the NNSA since 2010.

The Janesville construction permit for the radioisotope manufacturing facility was approved in Feburary and is planned to begin in 2017.

Read more about SHINE’s plans in Janesville at Healthcare Business.

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.